BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31147318)

  • 1. Risk of invasive bacterial infections by week of age in infants: prospective national surveillance, England, 2010-2017.
    Ladhani SN; Henderson KL; Muller-Pebody B; Ramsay ME; Riordan A
    Arch Dis Child; 2019 Sep; 104(9):874-878. PubMed ID: 31147318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Procalcitonin Assays to Predict Serious Bacterial Infection in Young Febrile Infants.
    Milcent K; Faesch S; Gras-Le Guen C; Dubos F; Poulalhon C; Badier I; Marc E; Laguille C; de Pontual L; Mosca A; Nissack G; Biscardi S; Le Hors H; Louillet F; Dumitrescu AM; Babe P; Vauloup-Fellous C; Bouyer J; Gajdos V
    JAMA Pediatr; 2016 Jan; 170(1):62-9. PubMed ID: 26595253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive bacterial infections in young afebrile infants with a history of fever.
    Mintegi S; Gomez B; Carro A; Diaz H; Benito J
    Arch Dis Child; 2018 Jul; 103(7):665-669. PubMed ID: 29449214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive bacterial infection in children with fever and petechial rash in the emergency department: a national prospective observational study.
    Storch-De-Gracia P; Fernández JL; Velasco R; Saez I; Rodrigo R; Yañez S; Castellarnau E; Gil E; Del Rio P; Garrido E; Castaño A; Perez Á; Cabrerizo M; Hernández M; Pérez JJ; de la Torre MJ; Nadal G; Martínez J; Sánchez-Tatay V
    Arch Dis Child; 2023 Jun; 108(6):445-450. PubMed ID: 37019466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of blood biomarkers to rule out invasive bacterial infection in febrile infants under 21 days old.
    Gomez B; Diaz H; Carro A; Benito J; Mintegi S
    Arch Dis Child; 2019 Jun; 104(6):547-551. PubMed ID: 30498061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study.
    Okike IO; Ribeiro S; Ramsay ME; Heath PT; Sharland M; Ladhani SN
    Lancet Infect Dis; 2014 Apr; 14(4):301-7. PubMed ID: 24508198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immature neutrophils in young febrile infants.
    Ramgopal S; Walker LW; Nowalk AJ; Cruz AT; Vitale MA
    Arch Dis Child; 2019 Sep; 104(9):884-886. PubMed ID: 31221623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Multicenter Study of Leukopenia in Infants Younger Than Ninety Days With Fever Without Source.
    Gomez B; Mintegi S; Benito J;
    Pediatr Infect Dis J; 2016 Jan; 35(1):25-9. PubMed ID: 26379161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data.
    Harcourt S; Morbey RA; Bates C; Carter H; Ladhani SN; de Lusignan S; Smith GE; Elliot AJ
    Vaccine; 2018 Jan; 36(4):565-571. PubMed ID: 29246475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of invasive bacterial infection in febrile infants ≤90 days with a COVID-19 positive test: a systematic review and meta-analysis.
    Pérez-Porra S; Granda E; Benito H; Roland D; Gomez B; Velasco R
    Emerg Med J; 2024 Mar; 41(4):228-235. PubMed ID: 38071527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance.
    Okike IO; Johnson AP; Henderson KL; Blackburn RM; Muller-Pebody B; Ladhani SN; Anthony M; Ninis N; Heath PT;
    Clin Infect Dis; 2014 Nov; 59(10):e150-7. PubMed ID: 24997051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febrile young infants with altered urinalysis at low risk for invasive bacterial infection. a Spanish Pediatric Emergency Research Network's Study.
    Velasco R; Benito H; Mozún R; Trujillo JE; Merino PA; Mintegi S;
    Pediatr Infect Dis J; 2015 Jan; 34(1):17-21. PubMed ID: 25036049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England.
    Ladhani SN; Andrews N; Parikh SR; Campbell H; White J; Edelstein M; Bai X; Lucidarme J; Borrow R; Ramsay ME
    N Engl J Med; 2020 Jan; 382(4):309-317. PubMed ID: 31971676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of the lab-score in predicting severe and invasive bacterial infections in well-appearing young febrile infants.
    Bressan S; Gomez B; Mintegi S; Da Dalt L; Blazquez D; Olaciregui I; de la Torre M; Palacios M; Berlese P; Ruano A
    Pediatr Infect Dis J; 2012 Dec; 31(12):1239-44. PubMed ID: 22760529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein or erythrocyte sedimentation rate results reliably exclude invasive bacterial infections.
    Paydar-Darian N; Kimia AA; Monuteaux MC; Michelson KA; Landschaft A; Maulden AB; Chenard RL; Nigrovic LE
    Am J Emerg Med; 2019 Aug; 37(8):1510-1515. PubMed ID: 30459011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of infant Gram-negative invasive bacterial infections in England, 2011-2019: an observational study using population-wide surveillance data.
    Hallmaier-Wacker LK; Andrews A; Hope R; Demirjian A; Lamagni TL; Collin SM
    Arch Dis Child; 2023 Sep; 108(9):762-767. PubMed ID: 37280043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted empiric antibiotic therapy for children with non-oncological comorbidities and community-onset invasive bacterial infections.
    Wells R; Le Doare K; Sharland M; Heath P; Ladhani SN;
    J Infect; 2015 Sep; 71(3):294-301. PubMed ID: 25964234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009.
    Wilson J; Guy R; Elgohari S; Sheridan E; Davies J; Lamagni T; Pearson A
    J Hosp Infect; 2011 Nov; 79(3):211-7. PubMed ID: 21764174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.